Mexico Chondroitin Sulfate Market Size & Outlook
Mexico chondroitin sulfate market, 2017-2030 (US$M)
Related Markets
Mexico chondroitin sulfate market highlights
- The Mexico chondroitin sulfate market generated a revenue of USD 49.8 million in 2022 and is expected to reach USD 63.5 million by 2030.
- The Mexico market is expected to grow at a CAGR of 3.1% from 2023 to 2030.
- In terms of segment, bovine was the largest revenue generating source in 2022.
- Synthetic is the most lucrative source segment registering the fastest growth during the forecast period.
Chondroitin sulfate market data book summary
| Market revenue in 2022 | USD 49.8 million |
| Market revenue in 2030 | USD 63.5 million |
| Growth rate | 3.1% (CAGR from 2022 to 2030) |
| Largest segment | Bovine |
| Fastest growing segment | Synthetic |
| Historical data | 2017 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Bovine, Swine, Poultry, Shark, Synthetic |
| Key market players worldwide | Merck KGaA, BRF SA ADR, Seikagaku, TSI Group, Bioiberica, Bio-gen Extracts |
Other key industry trends
- In terms of revenue, Mexico accounted for 4.1% of the global chondroitin sulfate market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. chondroitin sulfate market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 451.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Chondroitin Sulfate Market Scope
Chondroitin Sulfate Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Mexico chondroitin sulfate market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to chondroitin sulfate market will help companies and investors design strategic landscapes.
Bovine was the largest segment with a revenue share of 38.55% in 2022. Horizon Databook has segmented the Mexico chondroitin sulfate market based on bovine, swine, poultry, shark, synthetic covering the revenue growth of each sub-segment from 2017 to 2030.
Pharmaceutical industry in Mexico is one of the emerging industries in Latin America. It consists of a large number of domestic and multinational players engaged in manufacturing products including cancer treatment products, antibiotics, a variety of over-the-counter medicines, vaccines, and other products.
The Mexican law requires the companies distributing pharmaceuticals to have a manufacturing facility in the country, which is expected to contribute to foreign investments in the country. Foreign investments are anticipated to contribute to product development, manufacturing facilities, and growth in pharmaceutical products production.
These initiatives are projected to drive the market growth. The country has a large number of aging populations suffering from chronic diseases such as diabetes, cancer, and cardiovascular. In addition, it has a presence of multinational players including Johnson & Johnson, Roche, Pfizer, Sanofi, Merck, Novartis, Gilead, GlaxoSmithKline, and Amgen.
Reasons to subscribe to Mexico chondroitin sulfate market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Mexico chondroitin sulfate market databook
-
Our clientele includes a mix of chondroitin sulfate market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico chondroitin sulfate market , including forecasts for subscribers. This country databook contains high-level insights into Mexico chondroitin sulfate market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Mexico chondroitin sulfate market size, by source, 2017-2030 (US$M)
Mexico Chondroitin Sulfate Market Outlook Share, 2022 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
